LAMP1 and B-cell chronic lymphocytic leukemia: Finally, we measured the levels of intracellular IFNγ and TNFα cytokines, MIP-1β chemokine, and CD107a degranulation marker expressed by NK cells in the PBMCs from the CLL patients after exposure to K562 and treatment with IL15 or scFvB1IL15.